293
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Effect of transcutaneous electrical stimulation on nociception and edema induced by peripheral serotonin

, , , &
Pages 507-515 | Received 02 Oct 2012, Accepted 16 Jan 2013, Published online: 15 Mar 2013

References

  • APTA, American Physical Therapy Association. Guide to physical therapy practice. Phys Ther 1997;77;11:1163–1650.
  • Sluka KA, Lisi TL, Westlund, KN. Increased release of serotonin in the spinal cord during low, but not high, frequency transcutaneous electric nerve stimulation in rats with joint inflammation. Arch Phys Med Rehabil 2006;87:1137–40.
  • Walsh DM, Howe TE, Johnson MI, Sluka KA. 2009. Transcutaneous electrical nerve stimulation for acute pain. Cochrane Database Syst Rev 2009;15:CD006142.
  • Radhakrishnan R, King EW, Dickman JK, Herold CA, Johnston NF, Spurgin ML, Sluka KA. Spinal 5-HT2 and 5-HT3 receptors mediate low, but not high, frequency TENS-induced antihyperalgesia in rats. Pain 2003;5:205–13.
  • Sluka KA, Walsh D. Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness. J Pain 2003;4:109–21.
  • Sabino GS, Santos CMF, Francischi JN, Resende MA. Release of endogenous opioids following transcutaneous electric nerves stimulation in an experimental model of acute inflammatory pain. J Pain 2008;9:157–63.
  • Machelska H, Stein C. Immune mechanisms in pain control. Anesth & Anal 2002;95:1002–08.
  • Sommer C. Serotonin in pain and analgesia: actions in the periphery. Mol Neurobiol 2004;30:117–25.
  • Sufka KJ, Schomburg FM, Giordano J. Receptor mediation of 5-HT-induced inflammation and nociception in rats. Pharmacol Biochem Behav 1991;41:53–6.
  • Tambeli CH, Oliveira MC, Clemente JT, Pelegrini-da-Silva, Parada CA. A novel mechanism involved in 5-hydroxytryptamin-induced nociception: the indirect activation of primary afferents. Neuroscience 2006;141:1517–24.
  • Pierce PA, Xie GX, Peroutka SJ, Green PG, Levine JD. 5-hydroxytryptamine-induced synovial plasma extravasation is mediated via 5-hydroxytryptamine2a receptors on sympathetic efferent terminals. J Pharmacol Exp Ther 1995;275: 502–8.
  • Tokunaga A, Saika M, Senba E. 5-HT2A receptor subtype is involved in the thermal hyperalgesic mechanism of serotonin in the periphery. Pain 1998;76:349–55.
  • Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hiperalgesia. Pain 1988;32:77–88.
  • Resende MA, Gonçalves HH, Sabino GS, Pereira LSM, Francischi JN. Reduction in analgesic effect from low-frequency transcutaneous electrical nerve stimulation in morphine-tolerant rats. Rev Br Fisiot 2006;10:291–96.
  • Francischi JN, Dias MF, Rocha AO, de Abreu Castro MS, Kiyomi Funayama Tatsuo MA, Farinelli P, Pacheco CM, Ferreira-Alves DL, Sirois P. Pharmacological characterization of sephadex-induced oedema in rat paws: predominant role of serotonin and platelet-activating factor. Int Arch Allergy Immunol 1996;109:398–406.
  • Zarrindast MR, Sajedian M, Rezayat M, Ghazi-Khansari M. Effects of 5HT receptor antagonists on morphine-induced tolerance in mice. Eur J Pharmacol 1995;273:203–7.
  • Rodrigues ARA, Duarte IDG. The peripheral antinociceptive effect induced by morphine is associated with ATP-sensitive K+ channels. Br J Pharmacol 2000;129:110–4.
  • Sluka KA, Deacon M, Stibal A, Strissel S, Terpstra A. Spinal blockade of opioid receptors prevents the analgesia produced by tens in arthritic rats. J Pharmacol Exper Ther 1999;289:840–6.
  • Oliveira MC, Pelegrimi-da-Silva A, Parada CA, Tambeli CH. 5HT acts on nociceptive primary afferents through an indirect mechanism to induce hiperalgesia in the subcutaneous tissue. Neuroscience 2007;145:708–14.
  • Resende MA, Sabino CG, Cândido CRM, Pereira LSM, Francischi JN. Local transcutaneous electrical stimulation (TENS) effects in experimental inflammatory edema and pain. Eur J Pharmacol 2004;504:217–22.
  • Nitanda A, Yasunami N, Tokumo K, Fuju H, Hirai T, Nishio H. Contribution of the peripheral 5-HT2A receptor to mechanical hyperalgesia in a rat model of neuropathic pain. Neurochem Int 2005;47:394–400.
  • Centurion D, Mehotra S, Sánchez-López A, Gupta S, MaassenVanDenBrink A, Villalón CM. Potential vascular α1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat. Eur J Pharmacol 2006;535;234–42.
  • Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP. 1994. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Am Soc Pharmacol Exper Ther 1994;46:157–203.
  • Strachan AT, Leiper JB, Maughan RJ. Serotonin2C receptor blockade and thermoregulation during exercise in the heat. Med Sci Sports Exerc 2005;37:389–94.
  • Scott JA, Wood M, Flood P. The pronociceptive effect of ondansetron in the setting of p-glycoprotein inhibition. Anesth Analg 2006;103:742–6.
  • Taiwo YO, Levine JD. Serotonin is a directly-acting hyperalgesic agent in the rat. Neuroscience 1992;48:485–90.
  • Zeitz KP, Guy N, Malmberg AB, Dirajlal S, Martin WJ, Sun L, Bonhaus DW, Stucky CL, Julius D, Basbaum AL. The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. J Neurosci 2002;22:1010–19.
  • Inoue H, Nagata N, Koshihara Y. Participation of serotonin in capsaicin-induced mouse ear edema. Jpn J Pharmacol 1995;69:61–8.
  • Pierce PA, Xie G, Peroutka SJ, Green PG, Levine JD. 5-hydroxytryptamine-induced synovial plasma extravasation is mediated via 5-hydroxytryptamine2a receptors on sympathetic efferent terminals. J Pharmacol Exp Ther 1995;275: 502–8.
  • Gopalkrishnan P, Sluka KA. Effect of varying frequency, intensity and pulse duration of transcutaneous electrical nerve stimulation on primary hyperalgesia in inflamed rats. Arch Phys Med Rehabil 2000;81:984–90.
  • Sluka KA, Bailey K, Bogush J, Olson R, Ricketts A. Treatment with either high or low frequeny TENS reduces the secondary hyperalgesia observed after injection of Kaolin and carrageenan into the knee joint. Pain 1998;77:97–102.
  • Hughes GS Jr, Lichstein PR, Whitlock D, Harker C. Response of plasma beta-endorphins to transcutaneous electrical nerve stimulation in healthy subjects. Phys Ther 1984;64: 1062–6.
  • Kalra A, Urban MO, Sluka KA. Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (tens). J Phamacol Exper Ther 2001;298:257–63.
  • Dhawan BN, Cesselin F, Raghubir R, Reisine T, Bradley PB, Portoghese PS, Hamon M. International union of pharmacology. XII classification of opioid receptors. Pharmacol Rev 1996;48:567–92.
  • Hong Y, Abbott FV. Peripheral opióide modulation of pain and inflammation in the formalin test. Eur J Pharmacol 1995;227:21–8.
  • Obara I, Makuch W, Spetea M, Schutz J, Schmidhammer H, Przewlocki R, Przewlocka B. Local peripheral antinociceptive effects of 14-o-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat. Eur J Pharmacol 2007;558:60–7.
  • Stein C, Hassan AHS. Local analgesic effect of endogenous opioid peptides. Lancet 1993;342:321–7.
  • Stein C, Lang LJ. Peripheral mechanisms of opioid analgesia. Curr Opin Pharmacol 2009;9:3–8.
  • Stein C, Schäfer M, Machelska H. Attacking pain at its source: new perspectives on opioids. Nat Med 2003;9:1003–8.
  • Mousa SA, Straub RH, Schäfer M, Stein C. β-Endorphin, met-enkephalin and corresponding opióid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthristis. Ann Rheum Dis 2007;66:871–9.
  • Ibrahim MM, Porreca F, Lai J, Albrecht PJ, Rice FL, Khodorova A, Davar G, Makriyannis A, Vanderah TW, Mata HP, Malan TP Jr. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Nat Acad Sci 2005;102:3093–8.
  • Machelska H, Stein C. Immune mechanisms in pain control. Anesth & Anal 2002;95:1002–8.
  • Stein C, Clark JD, Oh U. Peripheral mechanisms of pain and analgesia. Brain Res Rev 2009;60:90–113.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.